BRAINBox provides objective evidence of injury and prediction of patient recovery.
BRAINBox Solutions has raised $7.1M in total funding. The most recent round was Series B. The last funding was announced in October 2023.
BRAINBox Solutions's investors include Genoa Ventures, Astia Angels, Bioventures Investors, National Institute of Neurological Disorders and Stroke, Pharmakon Advisors.
BRAINBox Solutions is headquartered in Richmond, United States.
BRAINBox provides objective evidence of injury and prediction of patient recovery.
BRAINBox Solutions is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BRAINBox Solutions — Funding & Investors." VCBacked, October 30, 2023, https://www.vcbacked.co/company/brainbox-solutions. Accessed August 1, 2026.
VCBacked. (2023). BRAINBox Solutions — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/brainbox-solutions
{{cite web |title=BRAINBox Solutions — Funding & Investors |url=https://www.vcbacked.co/company/brainbox-solutions |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated